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Abstract
Background: We have previously reported that intestinal epithelium-specific TAK1 deleted mice exhibit severe
inflammation and mortality at postnatal day 1 due to TNF-induced epithelial cell death. Although deletion of TNF receptor
1 (TNFR1) can largely rescue those neonatal phenotypes, mice harboring double deletion of TNF receptor 1 (TNFR1) and
intestinal epithelium-specific deletion of TAK1 (TNFR1KO/TAK1
IEKO) still occasionally show increased inflammation. This
indicates that TAK1 is important for TNF-independent regulation of intestinal integrity.
Methodology/Principal Findings: In this study, we investigated the TNF-independent role of TAK1 in the intestinal
epithelium. Because the inflammatory conditions were sporadically developed in the double mutant TNFR1KO/TAK1
IEKO
mice, we hypothesize that epithelial TAK1 signaling is important for preventing stress-induced barrier dysfunction. To test
this hypothesis, the TNFR1KO/TAK1
IEKO mice were subjected to acute colitis by administration of dextran sulfate sodium
(DSS). We found that loss of TAK1 significantly augments DSS-induced experimental colitis. DSS induced weight loss,
intestinal damages and inflammatory markers in TNFR1KO/TAK1
IEKO mice at higher levels compared to the TNFR1KO
control mice. Apoptosis was strongly induced and epithelial cell proliferation was decreased in the TAK1-deficient intestinal
epithelium upon DSS exposure. These suggest that epithelial-derived TAK1 signaling is important for cytoprotection and
repair against injury. Finally, we showed that TAK1 is essential for interleukin 1- and bacterial components-induced
expression of cytoprotective factors such as interleukin 6 and cycloxygenase 2.
Conclusions: Homeostatic cytokines and microbes-induced intestinal epithelial TAK1 signaling regulates cytoprotective
factors and cell proliferation, which is pivotal for protecting the intestinal epithelium against injury.
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Introduction
The intestinal epithelium is a single cell layer that separates
lamina propria immune cells from luminal components including
food antigens and commensal or pathogenic bacteria [1,2] The
integrity of the intestinal epithelium is essential for the mainte-
nance of intestinal homeostasis. The disruption of intestinal barrier
results in hyper-activation of mucosal immune cells, which
eventually could lead to the development of chronic inflammatory
diseases such as inflammatory bowel disease (IBD) in a susceptible
host. Although the etiology of IBD has not been fully elucidated, it
is well known that IBD is closely associated with an abnormal
response to the normal gut flora caused by the loss of intestinal
barrier [3,4]. Maintenance of this barrier depends on tight
regulation of epithelial cell proliferation and apoptosis [5]. It has
been demonstrated that commensal bacteria-derived signaling is
important for intestinal barrier maintenance following chemical-
induced injury [6]. Ablation of MyD88, a common signaling
intermediate of bacteria-derived signaling pathways, causes
dysregulated barrier function [6]. Commensal bacterial compo-
nents can initiate MyD88 signaling in epithelial cells as well as
immune cells in the intestine, both of which can modulate
epithelial cell proliferation and survival. It has been well studied
that homeostatic activation of immune cells is important for
production of cytokines and growth factors, which critically
regulate epithelial cell survival and proliferation [7]. However,
because epithelial cells are constantly exposed to bacteria and
several Toll-like receptors are downregulated [8], it is still unclear
whether bacteria-induced signaling in epithelial cells is also
important for barrier maintenance in the intestine.
Transforming growth factor-b activated kinase 1 (TAK1) is a
member of the mitogen activated protein kinases kinase kinase
(MAPKKK) family and plays an essential role in tumor necrosis
factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR)
signaling pathways [9,10,11] Furthermore, others and we have
recently identified that TAK1 is a central mediator of NOD-like
receptor (NLR) signaling [12,13,14]. In response to proinflamma-
tory cytokines or TLR/NLR ligands, TAK1 activates both NF-kB
and AP-1 pathways, which lead to activation of innate immune
response. TAK1 deficiency results in embryonic lethality,
therefore, conditional knockout systems have been used to reveal
the in vivo roles of TAK1. It has been identified that TAK1 is
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[10,15,16,17]. Thus, TAK1 is essential for proinflammatory
signaling in vivo as well as in cultured cells.
In addition to this proinflammatory function in immune cells,
we have recently demonstrated that TAK1 has a completely
opposite role in the skin and intestinal epithelium. TAK1 is
important for preventing inflammation in the skin and intestinal
epithelium [18,19]. We reported that intestinal epithelium-specific
TAK1 deleted mice (TAK1
IEKO) spontaneously developed
intestinal inflammation [18]. The TAK1-deficient intestinal
epithelium underwent significant apoptosis that is induced by
homeostatically expressed TNF in the intestine. The phenotype
was strongly attenuated by crossing TNF receptor 1 knockout
(TNFR12/2) mice, indicating that TNF is the major cause of
intestinal epithelial cell apoptosis and inflammation. However, a
fraction (40–50%) of the double knockout mice (TNFR1KO/
TAK1
IEKO) developed ileitis and colitis around the age of 14–17-
days-old [18], suggesting that TAK1 is also important for
preventing TNF-independent inflammation. Because TAK1 is
deleted only in epithelial cells in TNFR1KO/ TAK1
IEKO mice,
this protective signal is derived from epithelial cells. As described
above, TAK1 is activated by cytokines and TLR/NLR ligands.
Taken together, we hypothesize that intestinal epithelial TAK1 is
activated by cytokines and TLR/NLR ligands and maintains the
epithelial barrier. In this study, we tested this hypothesis by
analyzing TNFR1KO/TAK1
IEKO mice. The inflammatory
conditions in TNFR1KO/ TAK1
IEKO mice at the late neonatal
stage were transient and widely varied in each mouse [18].
Although some TNFR1KO/ TAK1
IEKO mice lost weight and
developed ileitis and colitis at 14–17 days as reported previously
[18], more than half of TNFR1KO/ TAK1
IEKO mice grew
normally and were indistinguishable from TNFR1KO control
mice after the age of 6-weeks-old. We speculate that the
inflammatory conditions at 14–17 days is associated with stress
caused by increased bacterial microflora in the intestine when the
mice start having solid food [20]. Thus, we postulate that TAK1
signaling is important for maintenance of intestinal barrier under
stress conditions. In order to study the TNF-independent role of
TAK1 in the intestinal barrier, we utilized adult TNFR1KO/
TAK1
IEKO mice and examined sensitivity to chemical-induced
acute colitis. We found that TAK1 deficiency caused hypersen-
sitivity to chemical-induced colitis involving increased apoptosis
and dysregulated cell proliferation, suggesting that epithelial
TAK1 signaling is cytoprotective.
Results
Intestinal epithelium-specific deletion of TAK1 enhances
DSS-induced intestinal damage
In order to investigate the hypothesis that epithelial-derived
TAK1 signaling is important for maintenance of intestinal barrier
under stress conditions, we exposed adult TNFR1KO/ TA-
K1
IEKO mice to dextran sulfate sodium (DSS), a chemical
disrupting the epithelium. TNFR1KO/TAK1
IEKO and litter-
mate control TNFR1KO mice were fed with 2.5% of DSS and
sacrificed at Day 5. The severity of DSS-induced colitis was
monitored by daily loss of body weight and observation of clinical
signs of acute inflammation such as rectal bleeding. DSS treatment
caused little weight loss or no apparent injury phenotype in the
control TNFR1KO mice. In contrast, the double mutant
TNFR1KO/TAK1
IEKO mice showed significant weight loss
and rectal bleeding starting from Day 4 (Fig. 1A and data not
shown). DSS-induced colon shortening, a marker for intestinal
damage, was also observed in TNFR1KO/TAK1
IEKO mice
(Fig. 1B and C). To further evaluate the role of TAK1 in DSS-
induced intestinal injury and inflammation, histological and
biochemical analyses were performed. Without DSS treatment,
the colon from TNFR1KO/TAK1
IEKO showed only slight signs
of inflammatory conditions and was almost indistinguishable from
TNFR1KO control mice (Fig. 2A and B). After 5 days of DSS
treatment, TAK1-deficient colon underwent complete loss of crypt
architecture and severe ulceration, whereas control mice showed
only mild damages characterized by epithelial hyperplasia and
immune cell infiltration (Fig. 2A and B). The structural damages in
TAK1-deficient colon might be associated with severe inflamma-
tion. To verify this possibility, the expression levels of inflamma-
tory genes were measured. After 5 days of DSS treatment, the
distal colons were isolated and the mRNA levels of chemokine
MIP2 (IL-8 in human) and chemotactic factor S100A9 were
determined by the real-time PCR. Both MIP2 and S100A9
expression was greatly upregulated in TAK1-deficient colon,
presumably due to an increased activity of infiltrated immune cell
(Fig. 2C). These data indicate that TAK1 signaling in the intestinal
epithelium protects against DSS-induced intestinal injury and
acute colitis.
TAK1 is required for intestinal epithelial cell survival
following DSS exposure
In order to protect the intestinal epithelium from DSS-induced
injury, two biological processes are essential; one is suppression of
apoptosis; and another is cell proliferation to repair lesions. We
first examined apoptosis in TNFR1KO/TAK1
IEKO and control
TNFR1KO mice. In the DSS colitis model, these biological events
precede clinical signs such as weight loss or rectal bleeding.
Therefore, we examined apoptosis in colonic epithelial cells in
mice exposed to DSS for 3 days, a time point preceding clinical
signs of colitis (Day 4) in the double mutant mice (Fig. 1A).
TUNEL staining was performed to assess apoptosis, and the
results revealed that DSS exposure induced more pronounced
apoptosis in the TAK1-deficient intestinal epithelium compared to
the control mice (Fig. 3A and B). In order to confirm this data, the
distal colon was isolated from DSS treated mice and the proteins
lysates were analyzed for caspase-3 processing using Western blot.
Consistent with the TUNEL result, the amount of cleaved caspase-
3 was greatly increased by the administration of DSS in the
TAK1-deficient colon, but not in control colon (Fig. 3C). These
data indicate that TAK1 is required for suppression of apoptosis
against DSS-induced intestinal damage.
Loss of TAK1 dysregulates proliferation of the intestinal
epithelium
We next examined epithelial cell proliferation. Intestinal
homeostasis is maintained by proliferation and differentiation of
the intestinal epithelial cells along the crypt axis. It has been
reported that commensal bacteria-mediated TLR signaling is
important for homeostatic level of proliferation of epithelial cells.
Depletion of commensal bacteria or loss of TLR signaling
abnormally upregulates the steady-state level of epithelium
proliferation and lead to increased sensitivity to chemical and
radiation-induced intestinal injury [6]. TAK1 is a key mediator of
bacteria-induced signaling pathways, TLR/NLR signalings. Thus,
we hypothesize that TAK1-deficient intestinal epithelial cells do
not respond to commensal bacteria, which may dysregulate cell
proliferation along the crypt axis. This may be associated with
increased sensitivity to DSS-induced injury. To address this
possibility, we examined the base line proliferating status in the
intestinal epithelium of control TNFR1KO and TNFR1KO/
TAK1 Role in the Intestine
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IEKO mice. Proliferating cells were labeled by 5-bromo-29-
deoxyuridine (BrdU) that was injected 2 h prior to harvesting
distal colon. Immunohistochemical analysis was performed to
detect BrdU labeled cells. Interestingly, we found significantly
increased proliferating cells in TAK1 deficient intestinal epithe-
lium (Fig. 4A and B). Of note, whereas proliferating cells were
restricted in the bottom regions of the crypts (stem cell area) in
control TNFR1KO mice, a large fraction of proliferating cells was
found in the middle or upper region of the crypts in the
TNFR1KO/TAK1
IEKO mice. It is known that DSS-induced
injury induce compensatory cell proliferation responses in mice
[6]. Mice were fed with 2.5% DSS for 3 days and proliferating
cells were examined by BrdU. Cell proliferation was not altered by
DSS treatment in control TNFR1KO mice (Fig. 4A and B), which
is consistent with the results showing no severe injury in the control
mice under 2.5% DSS treatment (Fig. 1). In TNFR1KO/
TAK1
IEKO mice, the length and structure of crypts were still
relatively intact at 3 days with 2.5% DSS treatment (Fig. 4B, H&E
staining). However, we found a dramatic reduction of cell
proliferation in TAK1-deficient intestinal epithelium after DSS
exposure (Fig. 4A and B, BrdU staining). This indicates that
reparative cell proliferation is impaired in TAK1-deficient
Figure 1. Loss of TAK1 in the intestinal epithelium results in worsened clinical signs of DSS-induced colitis. A Intestinal epithelium-
specific TAK1/TNFR1 double knockout mice (TNFR1KO/TAK1
IEKO) and control TNFR1 single knockout mice (TNFR1 KO) were fed with 2.5% DSS. Mice
were weighed daily to access weight loss. Each point represents a mean value6SE. (N=8 per group, *=p,0.05, **=p,0.01). B Colons of TNFR1KO/
TAK1
IEKO and TNFR1 KO were removed at days 0 and 5 of 2.5% DSS administration and the colon length was measured. Each bar represents a mean
value6SE (N=6 for water control; N=9 for DSS, **=p,0.01, NS=not significant). C Photograph of representative colon at day 5 of DSS
administration.
doi:10.1371/journal.pone.0004561.g001
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TAK1 deficiency results in the disruption of homeostatic epithelial
cell proliferation and impairs compensatory epithelial cell
proliferation after DSS-induced injury, which might be responsible
for greater sensitivity to the injury-mediated inflammation.
TAK1 is required for proinflammatory cytokine- and
bacterial components-induced cytoprotective gene
expression
We next investigated the mechanism by which epithelial TAK1
signaling protects against DSS-induced injury. We examined
activation of TAK1 pathway, cell proliferation and cell survival in
cultured cells. Because primary culture of intestinal epithelial cells
is technically difficult due to detachment-induced apoptosis
(anoikis) during the isolation procedure [21], we utilized intestinal
epithelial cell lines, keratinocytes and dermis fibroblasts as model
systems. We first examined whether DSS affects TAK1 signaling
including activation of NF-kB and MAPK pathways. We found
that DSS barely activated NF-kB or MAPKs in the intestinal
epithelial cell lines including HT-29 and Caco2 as well as
keratinocytes (data not shown). We next examined whether TAK1
deletion alters the cell proliferation and survival using wild-type
and TAK1-deficient cells. We found that TAK1-deficient
Figure 3. TAK1 protects the intestinal epithelium from apoptosis in response to DSS-induced damage. A Distal colon was isolated from
TNFR1KO and TNFR1KO/TAK1
IEKO mice treated with water or 2.5% DSS for 3 days. To detect apoptotic cells, TUNEL staining was performed and
TUNEL positive cells were counted. Each bar represents a mean value6SE (N=4 for water control; N=5 for DSS, **=p,0.01, NS=not significant). B
Representative TUNEL staining. C Distal colon was isolated from TNFR1KO and TNFR1KO/TAK1
IEKO mice treated with 2.5% DSS for 3 days. Cell extract
was isolated and subjected to immunoblotting using caspase-3 antibody. b-actin was used for loading control.
doi:10.1371/journal.pone.0004561.g003
Figure 2. Loss of TAK1 in the intestinal epithelium leads to severe epithelial damage and upregulates inflammatory gene
expression in response to DSS. A Histologic damage was scored from H&E staining sections of distal colon from TNFR1KO and TNFR1KO/
TAK1
IEKO mice treated with water or 2.5% DSS for 5 days. Each bar represents a mean value6SE (N=6 for water control; N=9 for DSS, **=p,0.01,
NS=not significant). B Representative H&E staining. Scale bars, 100 mm. C Total RNA was isolated from distal colon of TNFR1KO and TNFR1KO/
TAK1
IEKO mice at day 5 of DSS administration and reverse transcribed. The expression of inflammatory genes was measured using quantitative real-
time PCR. Each bar represents a mean value6SE (N=5 per group, **=p,0.01).
doi:10.1371/journal.pone.0004561.g002
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PLoS ONE | www.plosone.org 5 February 2009 | Volume 4 | Issue 2 | e4561Figure 4. Loss of TAK1 disrupts homeostatic proliferation of the intestinal epithelium. A Distal colon was isolated from TNFR1KO and
TNFR1KO/TAK1
IEKO mice treated with water or 2.5% DSS for 3 days. Mice were injected with 0.1 mg/g of 5-bromo-29-deoxyuridine (BrdU) 2 h prior to
sacrifice. Immunostaining for BrdU was performed and BrdU-positive cells were counted. Each bar represents a mean value6SE (N=5 per group,
**=p,0.01). B Representative BrdU staining and H&E staining at 3 days DSS treatment. Original magnifications;6200 (BrdU staining) and640 (H&E
staining).
doi:10.1371/journal.pone.0004561.g004
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proliferation or increased cell death upon DSS treatment (data not
shown). These indicate that DSS does not directly activate TAK1
pathway, and that TAK1 signaling does not cell-autonomously
regulate cell death or proliferation in response to DSS exposure.
Based on these findings, we postulate that epithelial TAK1 is
activated not by DSS but by cytokines and TLR/NLR ligands that
are upregulated by DSS-induced injury, and that TAK1 signaling
may induce production of cytoprotective factors and facilitate
epithelial cell survival and proliferation. To address this hypoth-
esis, we tested whether TAK1 is required for expression of
cytoprotective factors, interleukin 6 (IL-6) and cycloxygenase 2
(COX2), following exposure of activators of TAK1 signaling, IL-1,
LPS and the NOD2 ligand, muramyl dipeptide (MDP). We found
that TAK1 is required for IL-1-induced IL-6 and COX2
expression in fibroblasts (Fig. 5A). LPS also induced IL-6
expression in a TAK1 dependent manner in fibroblasts (Fig. 5A).
In wild type keratinocytes, both IL-1 and LPS failed to induce IL-6
and COX2 expression (data not shown), because keratinocytes do
not strongly respond to LPS and IL-1 stimulation. However, MDP
strongly upregulated the levels of IL-6 and COX2 in wild type
keratinocytes, and a process completely abolished by the loss of
TAK1 (Fig. 5B). These data suggest that epithelial TAK1 signaling
is essential for production of cytoprotective factors.
Discussion
In this study, we demonstrated that intestinal epithelium-
derived TAK1 signaling plays a pivotal role in preventing injury-
induced intestinal inflammation. In the absence of TAK1-derived
signaling, the intestinal epithelium is exquisitely sensitive to DSS-
induced injury, a process involving increased epithelial cell
apoptosis and reduced regenerative proliferative responses.
This pathologic response further induces damage-associated
Figure 5. TAK1 is required for the expression of protective factors in response to proinflammatory cytokine or bacterial
components. A TAK1 WT and KO dermis fibroblasts (DF) were stimulated with 5 ng/ml of IL-1b or 2 mg/ml of LPS for 6 h. The expression of IL-6 and
COX2 was examined by quantitative real-time PCR. mRNA levels were normalized with the levels of GAPDH. Relative mRNA levels were calculated
using those of untreated TAK1 WT dermis fibroblasts. Data are mean6S.E. of three independent samples and representative of three independent
experiments with similar results. B TAK1 WT and KO keratinocytes (KC) were stimulated with 10 mg/ml of MDP for 6 h. The expression of IL-6 and
COX2 was examined as described above.
doi:10.1371/journal.pone.0004561.g005
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expansion of the epithelial cell proliferative zone under steady-
state conditions, and causes impaired reparative proliferation after
injury. Finally, we showed that loss of TAK1 abolishes production
of cytoprotective factors in response to proinflammatory cytokines
and bacterial components. Taken together, we propose that
TAK1 is essential for preventing injury-associated intestinal
inflammation by the following two mechanisms. One is that
TAK1 is responsible for maintenance of homeostatic proliferation
of the intestinal epithelium, and that dysregulated cell proliferation
causes hypersensitivity to cytotoxic insults. Intestinal epithelial cells
are originated from stem cells located in the bottom of crypts [2].
The intestinal stem cell-derived epithelial cells are proliferating
until terminally differentiated. The population of these proliferat-
ing cells is tightly regulated. We found that the steady-state level of
proliferation is abnormally upregulated in the TAK1-deficient
intestinal epithelium. Although increased proliferating cells may be
beneficial for tissue repair, proliferating cells are usually hyper-
sensitive to cytotoxic insults. It is well exemplified in the case of
cancer therapy. The gastrointestinal tract, oral mucosa and
hematopoietic cells, which are all highly proliferative, are the
most sensitive to chemotherapy. Another mechanism is that
epithelial TAK1 signaling induces cytoprotective factors, and that
ablation of this pathway causes increased apoptosis and degener-
ation of the intestinal barrier. We found that TAK1 is essential for
IL-1, LPS and MDP-induced expression of IL-6 and COX2, both
of which are known to play an important role in protecting the
intestinal epithelium against DSS-induced injury [22,23,24,25].
Commensal bacteria and homeostatic cytokines activate TAK1 in
the intestinal epithelium, and the activated TAK1 induces
cytoprotective factors including IL-6 and COX2. We propose
that this pathway is essential for the maintenance of intestinal
barrier integrity.
TAK1 can activate two major transcription factors, NF-kB and
AP-1. NF-kB is a key transcription factor implicated in the
regulation of both IL-6 and COX2 gene expression [26].
Pharmacological blockage of NF-kB inhibits production of
COX2 in intestinal epithelial cells and enhances DSS-induced
colitis [23]. Therefore, TAK1-NF-kB signaling pathway in
intestinal epithelial cells may be the major pathway for
maintenance of the intestinal barrier. However, intestinal
epithelial-specific NEMO (IKKc) deletion mice, which is deficient
in NF-kB activation, develop TNF-dependent but not TNF-
independent intestinal inflammation [27]. Therefore, whereas
TAK1-NF-kB pathway participates in prevention of TNF-induced
cell death and inflammation, TAK1-dependent but NF-kB-
independent pathways are also important for the intestinal barrier
function.
How does TAK1 deletion cause increased basal cell prolifer-
ation in the intestinal epithelium? It has been established that
proliferation of the intestinal epithelium depends on the concerted
action of several factors including Wnt (positive regulator of cell
cycle) and TGF-b signaling (negative regulator of cell cycle)
[2,28,29,30]. TAK1 is involved in both Wnt (negatively) and
TGF-b (positively) signaling pathways in cultured cells
[31,32,33,34]. Therefore, TAK1 deletion may affect epithelial
cell proliferation through dysregulating Wnt or TGF-b signaling.
However, we note that intestinal epithelial-specific deletion of
TAK1 does not alter epithelial cell proliferation and differentiation
at least during embryogenesis [18]. Therefore, TAK1 is not a
major signaling intermediate of Wnt and TGF-b signaling in the
intestinal epithelium. Besides Wnt and TGF-b signalings, intestinal
epithelial proliferation is regulated by innate immune signaling [6].
MyD88-deficient mice show increased proliferation in the
intestinal epithelium [6], which is similar to our TNFR1KO/
TAK1
IEKO mice. It has been reported that NF-kB p50-deficient
intestinal epithelium also shows extensive proliferative zones [35],
and that NF-kB signaling has been reported to inhibit cell
proliferation in epithelial tissues [36]. TAK1 is a signaling
intermediate of MyD88-NF-kB pathway [37]. Therefore,
MyD88-TAK1-NF-kB pathway may function to limit the
proliferative zones in the intestinal epithelium by preventing
epithelial cell proliferation.
TLR- or MyD88-deficient mice and commensal bacteria-
depleted mice showed very similar phenotypes observed in our
TNFR1KO/TAK1
IEKO mice that are characterized by in-
creased susceptibility to DSS-induced injury, dysregulated
steady-state levels of cell proliferation and impaired production
of cytoprotective factors [6]. Rakoff-Nahoum et al. proposed that
commensal bacteria-induced signaling is important for mainte-
nance of the intestinal barrier. Failure to initiate activation of these
signaling pathways increases susceptibility of the intestinal
epithelium to chemical or radiation-induced injury. However,
because these studies have used germline knockout of TLR4,
TLR2 and MyD88, it is not clear whether epithelial cell- or
immune cell-derived signaling is responsible for maintaining
barrier integrity. Our results demonstrated that epithelial-derived
TAK signaling is important for the maintenance of intestinal
homeostasis. It should also be of interest to determine the
contributions of immune cell-derived TAK1 signaling to the
barrier maintenance.
Loss of intestinal epithelial barrier is associated with chronic
inflammatory diseases such as inflammatory bowel diseases (IBD).
Mutations in NOD2 gene are highly associated with IBD
susceptibility [3]. Our results indicate that TAK1 signaling is
essential for epithelial barrier maintenance. TAK1 is a key
mediator of NOD2 signaling [14]. Taken together, loss of NOD2-
TAK1 signaling in the intestinal epithelium may be one of the
causes to increase susceptibility of IBD. However, further
investigation will be needed to clarify the relationship between
TAK1 and the pathogenesis of IBD.
Materials and Methods
Mice and Induction of DSS Induced-Colitis
TNFR1KO/TAK1
IEKO mice and control TAK1
FL/FL
TNFR1
2/2 were generated as described in our previous study
[18]. All mice were on a C57BL/6 background and genotypes
were determined by PCR. For inducing acute colitis, 6 to 8 weeks-
old TNFR1KO/TAK1
IEKO mice and littermate control
TNFR1KO (TAK1
FL/FL TNFR1
2/2) were fed with 2.5% of
DSS. Mice were weighed daily and sacrificed at time points
indicated. Mice were bred and maintained under specific
pathogen-free conditions. All animal experiments were done with
the approval of the North Carolina State University Institutional
Animal Care and Use Committee.
Cells
Dermis fibroblasts were isolated from TAK11
FL/FL mice. The
cells were spontaneously immortalized and infected with pMX-
puro-CRE retroviral vector to delete tak1 gene. Uninfected cells
were removed by puromycin selection and the deletion of TAK1
was confirmed by immunoblotting. The cells were maintained in
DMEM containing 10% bovine growth serum (HyClone) and 1%
penicillin/streptomycin. TAK1 WT and KO keratinocytes were
isolated from epidermis-specific TAK1 deletion mice and
maintained in keratinocyte medium as described in our previous
publication [19]
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After 5 days of DSS treatment, distal colons were isolated and
fixed in 10% formalin. Paraffin-embedded sections were stained
with H&E for histological analysis. Sections were scored in a
blinded fashion on a scale from 0 to 4, based on the degree of
lamina propria mononuclear cell infiltration, crypt hyperplasia,
goblet cell depletion, and architectural distortion, as previously
described [38]. Apoptotic cells were detected after 3 days of DSS
treatment using the DeadEnd colorimetric TUNEL system
(Promega) according to the manufacturer’s instructions. To detect
proliferating cells, mice were injected with 0.1 mg/g of BrdU 2 h
prior to sacrifice. Immunohistochemical analysis was performed
using anti-BrdU antibody (Becton Dickinson).
Real-time PCR analysis
Total RNA was prepared from distal colons or cells using
RNeasy minikit (Qiagen). To obtain cDNA, 200 ng of each RNA
samples were reverse-transcribed using TaqMan reverse tran-
scription reagents (Applied Biosystems). Real-time PCR analysis
was performed using the ABI PRISM 7300 sequence detection
system (Applied Biosystems). All samples were normalized by the
amount of glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
expression.
Immunoblotting
After DSS exposure, distal colons were harvested and
homogenized in an extraction buffer (20 mM HEPES (pH 7.4),
150 mM NaCl, 12.5 mM b-glycerophosphate, 1.5 mM MgCl2,
2 mM EGTA, 10 mM NaF, 2 mM DTT, 1 mM Na3VO4,1m M
PMSF, 100 U/ml aprotinin, 0.5% Triton X-100). Proteins from
cell lysates were electrophoresed by SDS-PAGE and transferred to
Hybond-P (GE Healthcare). The membranes were immuno-
blotted with a polyclonal antibody against caspase-3 (Cell
signaling) and a mouse antibody against b-actin (Sigma-Aldrich).
Bound antibodies were visualized with HRP-conjugated antibod-
ies against rabbit or mouse IgG using the ECL Western blotting
system (GE Healthcare).
Statistical analysis
Statistical comparisons were made using paired or independent
two-tailed Student’s t tests assuming equal variance and two-tailed
Welch’s t tests assuming unequal variance.
Acknowledgments
We thank B.J. Welker and M. Mattmuler for support.
Author Contributions
Conceived and designed the experiments: JYK RKS EO CJ JNT.
Performed the experiments: JYK RKS EO. Analyzed the data: JYK JNT.
Wrote the paper: JYK CJ JNT.
References
1. Ley RE, Peterson DA, Gordon JI (2006) Ecological and evolutionary forces
shaping microbial diversity in the human intestine. Cell 124: 837–848.
2. Radtke F, Clevers H (2005) Self-renewal and cancer of the gut: two sides of a
coin. Science 307: 1904–1909.
3. Bouma G, Strober W (2003) The immunological and genetic basis of
inflammatory bowel disease. Nat Rev Immunol 3: 521–533.
4. Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory
bowel disease. Nature 448: 427–434.
5. Hall PA, Coates PJ, Ansari B, Hopwood D (1994) Regulation of cell number in
the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci
107: 3569–3577.
6. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R
(2004) Recognition of commensal microflora by toll-like receptors is required for
intestinal homeostasis. Cell 118: 229–241.
7. Medzhitov R (2007) Recognition of microorganisms and activation of the
immune response. Nature 449: 819–826.
8. Lotz M, Gutle D, Walther S, Menard S, Bogdan C, et al. (2006) Postnatal
acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med 203:
973–984.
9. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, et al. (1999) The
kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade
in the IL-1 signalling pathway. Nature 398: 252–256.
10. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, et al. (2005)
Essential function for the kinase TAK1 in innate and adaptive immune
responses. Nat Immunol 6: 1087–1095.
11. Shim JH, Xiao C, Paschal AE, Bailey ST, Rao P, et al. (2005) TAK1, but not
TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.
Genes Dev 19: 2668–2681.
12. da Silva Correia J, Miranda Y, Leonard N, Hsu J, Ulevitch RJ (2007) Regulation
of Nod1-mediated signaling pathways. Cell Death Differ 14: 830–839.
13. Hasegawa M, Fujimoto Y, Lucas PC, Nakano H, Fukase K, et al. (2008) A
critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kB
activation. Embo J 27: 373–383.
14. Kim JY, Omori E, Matsumoto K, Nunez G, Ninomiya-Tsuji J (2008) TAK1 is a
central mediator of NOD2 signaling in epidermal cells. J Biol Chem 283:
137–144.
15. Liu HH, Xie M, Schneider MD, Chen ZJ (2006) Essential role of TAK1 in
thymocyte development and activation. Proc Natl Acad Sci U S A 103:
11677–11682.
16. Sato S, Sanjo H, Tsujimura T, Ninomiya-Tsuji J, Yamamoto M, et al. (2006)
TAK1 is indispensable for development of T cells and prevention of colitis by the
generation of regulatory T cells. Int Immunol 18: 1405–1411.
17. Wan YY, Chi H, Xie M, Schneider MD, Flavell RA (2006) The kinase TAK1
integrates antigen and cytokine receptor signaling for T cell development,
survival and function. Nat Immunol 7: 851–858.
18. Kajino-Sakamoto R, Inagaki M, Lippert E, Akira S, Robine S, et al. (2008)
Enterocyte-derived TAK1 signaling prevents epithelium apoptosis and the
development of ileitis and colitis. J Immunol 181: 1143–1152.
19. Omori E, Matsumoto K, Sanjo H, Sato S, Akira S, et al. (2006) TAK1 is a
master regulator of epidermal homeostasis involving skin inflammation and
apoptosis. J Biol Chem 281: 19610–19617.
20. Menard S, Forster V, Lotz M, Gutle D, Duerr CU, et al. (2008)
Developmental switch of intestinal antimicrobial peptide expression. J Exp
Med 205: 183–193.
21. Yan SR, Joseph RR, Rosen K, Reginato MJ, Jackson A, et al. (2005) Activation
of NF-kB following detachment delays apoptosis in intestinal epithelial cells.
Oncogene 24: 6482–6491.
22. Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, et al. (2006)
Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation
and apoptosis in the intestine. Gastroenterology 131: 862–877.
23. Karrasch T, Kim JS, Jang BI, Jobin C (2007) The flavonoid luteolin worsens
chemical-induced colitis in NF-kB(EGFP) transgenic mice through blockade of
NF-kappaB-dependent protective molecules. PLoS ONE 2: e596.
24. Morteau O, Morham SG, Sellon R, Dieleman LA, Langenbach R, et al. (2000)
Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygen-
ase-1 or cyclooxygenase-2. J Clin Invest 105: 469–478.
25. Tebbutt NC, Giraud AS, Inglese M, Jenkins B, Waring P, et al. (2002)
Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-
mediated trefoil gene activation in gp130 mutant mice. Nat Med 8:
1089–1097.
26. Jobin C, Sartor RB (2000) The I kB/NF-kB system: a key determinant of
mucosalinflammation and protection. Am J Physiol Cell Physiol 278: C451–462.
27. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, et al. (2007) Epithelial
NEMO links innate immunity to chronic intestinal inflammation. Nature 446:
557–561.
28. Giles RH, van Es JH, Clevers H (2003) Caught up in a Wnt storm: Wnt
signaling in cancer. Biochim Biophys Acta 1653: 1–24.
29. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, et al. (1998)
Depletion of epithelial stem-cell compartments in the small intestine of mice
lacking Tcf-4. Nat Genet 19: 379–383.
30. Siegel PM, Massague J (2003) Cytostatic and apoptotic actions of TGF-beta in
homeostasis and cancer. Nat Rev Cancer 3: 807–821.
31. Hanafusa H, Ninomiya-Tsuji J, Masuyama N, Nishita M, Fujisawa J-i, et al.
(1999) Involvement of the p38 Mitogen-activated Protein Kinase Pathway in
Transforming Growth Factor-beta -induced Gene Expression. J Biol Chem 274:
27161–27167.
32. Ishitani T, Ninomiya-Tsuji J, Nagai S, Nishita M, Meneghini M, et al. (1999)
The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-
catenin and transcription factor TCF. Nature 399: 798–802.
TAK1 Role in the Intestine
PLoS ONE | www.plosone.org 9 February 2009 | Volume 4 | Issue 2 | e456133. Kajino T, Omori E, Ishii S, Matsumoto K, Ninomiya-Tsuji J (2007) TAK1
MAPK kinase kinase mediates transforming growth factor-beta signaling by
targeting SnoN oncoprotein for degradation. J Biol Chem 282: 9475–9481.
34. Kanei-Ishii C, Ninomiya-Tsuji J, Tanikawa J, Nomura T, Ishitani T, et al.
(2004) Wnt-1 signal induces phosphorylation and degradation of c-Myb protein
via TAK1, HIPK2, and NLK. Genes Dev 18: 816–829.
35. Inan MS, Tolmacheva V, Wang QS, Rosenberg DW, Giardina C (2000)
Transcription factor NF-kB participates in regulation of epithelial cell turnover
in the colon. Am J Physiol Gastrointest Liver Physiol 279: G1282–1291.
36. Seitz CS, Deng H, Hinata K, Lin Q, Khavari PA (2000) Nuclear factor
kB subunits induce epithelial cell growth arrest. Cancer Res 60:
4085–4092.
37. Kawai T, Akira S (2007) Signaling to NF-kB by Toll-like receptors. Trends Mol
Med 13: 460–469.
38. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, et al. (1998)
Resident enteric bacteria are necessary for development of spontaneous colitis
and immune system activation in interleukin-10-deficient mice. Infect Immun
66: 5224–5231.
TAK1 Role in the Intestine
PLoS ONE | www.plosone.org 10 February 2009 | Volume 4 | Issue 2 | e4561